Alcohol and hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Background: Alcohol is classified as a Group 1 carcinogen by the International Agency for Research on Cancer because it induces hepatocellular carcinoma (among other cancers) in humans. An excessive alcohol intake may result in fatty liver, acute/chronic hepatitis, and cirrhosis and eventually lead to hepatocellular carcinoma. It has been reported that alcohol abuse increases the relative risk of hepatocellular carcinoma by 3- to 10-fold. Aim and Methods: To clarify the known mechanisms of alcohol-related carcinogenesis, we searched Pubmed using the terms alcohol and immune mechanism, alcohol and cancer, and immune mechanism and cancer and summarized the articles as a qualitative review. Results: From a clinical perspective, it is well known that alcohol interacts with other factors, such as smoking, viral hepatitis, and diabetes, leading to an increased risk of hepatocellular carcinoma. There are several possible mechanisms through which alcohol may induce liver carcinogenicity, including the mutagenic effects of acetaldehyde and the production of ROS due to the excessive hepatic deposition of iron. Furthermore, it has been reported that alcohol accelerates hepatitis C virus-induced liver tumorigenesis through TLR4 signaling. Despite intense investigations to elucidate the mechanisms, they remain poorly understood. Conclusion: This review summarizes the recent findings of clinical and pathological studies that have investigated the carcinogenic effects of alcohol in the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is known that excessive alcohol consumption leads to a 3- to 10-fold increase in the risk of HCC and accounts for 30% of HCC cases worldwide [109,110].”
From Pathophysiological Aspects of Alcohol Metabolism in the Liver (2021) · cites this paper as [109]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alcohol is recognized as a carcinogen by the International Agency for Research on Cancer. This is because alcohol causes many types of cancers, including hepatocellular carcinoma (HCC) in humans [109].”
From Pathophysiological Aspects of Alcohol Metabolism in the Liver (2021) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, C.-L., Uthaya Kumar, D. B., Punj, V., Xu, J., Sher, L., Tahara, S. M., Hess, S., & Machida, K. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.004 · Cited by 388 · cited 1×
“lation of the mitochondrial metabolism in NS5A Tg mice.(110) These studies suggest the crucial involvement of”
BackgroundRetractedGlobal cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070 · cited 2×
“recommended by the European Association for the Study of the Liver.(7) 8 Incidentally, the previous AASLD guide-”
BackgroundInfluentialGender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
A meta-analysis of alcohol consumption and the risk of 15 diseases
Corrao, G. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2003.11.027 · Cited by 1,077
Research works printed but not linked: 2
- 10.1111/j.1530-0277.2001.tb02242.x · doi:10.1111/j.1530-0277.2001.tb02242.x · Paper page
- 10.1111/j.1530-0277.1997.tb04256.x · doi:10.1111/j.1530-0277.1997.tb04256.x · Paper page
Cited by
Pathophysiological Aspects of Alcohol Metabolism in the Liver
Hyun, J., Han, J., Lee, C., Yoon, M., & Jung, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115717 · Cited by 324
Coelho-Júnior, H. J., Trichopoulou, A., & Panza, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101395 · Cited by 216
Choi, S., Kim, B. K., Yon, D. K., Lee, S. W., Lee, H. G., Chang, H. H., Park, S., Koyanagi, A., Jacob, L., Dragioti, E., et al. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0316 · Cited by 100
Alcohol and hepatocarcinogenesis
Taniai, M. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0203 · Cited by 117
“It has been shown that estrogen increases the sensitivity of Kupffer cells to LPS, which results in more severe liver injury, and many previous studies have reported that more severe inflammatory responses in the liver and fat tissue, which were associated with TLR4 signaling, were seen in female patients.(5) In patie…”
BackgroundMethodInfluentialRole of alcohol in pathogenesis of hepatitis B virus infection
Ganesan, M., Eikenberry, A., Poluektova, L. Y., Kharbanda, K. K., & Osna, N. A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i9.883 · Cited by 61
Metadata
- Authors
- Matsushita, H., & Takaki, A.
- Affiliations
- Okayama University (JP)
- Corresponding author
- Takaki, Akinobu
- Venue
- BMJ Open Gastroenterology
- Publisher
- BMJ
- Published
- 2019-04
- Volume
- 6
- Issue
- 1
- Pages
- e000260
- ISSN
- 2054-4774 (ISSN-L)
- PMC
- PMC6505979
- OpenAlex
- W2933220359
- Cited by
- 110
- References
- 117
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 16 · 2023: 16 · 2022: 18 · 2021: 14 · 2020: 11 · 2019: 3
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- alcohol, hepatocellular carcinoma, acetaldehyde, reactive oxygen species, iron accumulation, TLR4 signaling, hepatitis C virus, liver cirrhosis, smoking, viral hepatitis, diabetes mellitus, immune mechanisms, carcinogenesis mechanisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alcohol and hepatocellular carcinoma. https://app.cochat.ai/papers/10.1136/bmjgast-2018-000260
- The paper
- Matsushita, H., & Takaki, A. (2019). Alcohol and hepatocellular carcinoma. BMJ Open Gastroenterology. https://doi.org/10.1136/bmjgast-2018-000260
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.